Reproductive Medicine Associates of New York, New York, USA.
Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, USA.
JBRA Assist Reprod. 2021 Oct 4;25(4):575-580. doi: 10.5935/1518-0557.20210011.
Although chromosomal heteromorphisms are commonly found in the general population, some researchers have suggested a correlation with higher rates of embryo aneuploidy. This study aimed to assess the rates of embryo aneuploidy in couples who carry a chromosome heteromorphism.
The study included couples who had G-banding karyotype testing and underwent an IVF/PGT-A cycle between January 2012 and March 2018. The participants were classified by couple karyotype: Group A: ≥1 patient reported to be a heterochromatic variant carrier; Group B: both partners reported to be "normal". We assessed the rates of aneuploidy among the groups. We ran a multivariate regression analysis to assess the relationship between heterochromatic variants and the rates of embryo aneuploidy.
Of the 946 couples analyzed, 48 (5.0%) reported being a carrier of ≥1 heterochromatic variant. We had 869 IVF/PGT-A cycles included in the analysis (Group A: n=48; Group B: n=82). There were no significant differences in embryo ploidy rates among the groups. The heterochromatic chromosome variant was not associated with increased likelihoods of aneuploidy (OR=1.04, CI:95% 0.85- 1.07; p=0.46). Finally, the gender of the heterochromatic variant carrier had no association with increased likelihood of aneuploidy (OR 1.02, CI 95% 0.81-1.28, p=0.82).
Our study showed no association between parental heterochromatic chromosome variants and subsequent embryo aneuploidy rates. Ploidy rates do not appear to be negatively associated with couples when at least one patient is reported to be a carrier of a heterochromatic variant on the karyotype.
尽管染色体异态性在普通人群中很常见,但一些研究人员认为其与胚胎非整倍体率升高有关。本研究旨在评估携带染色体异态性的夫妇胚胎非整倍体率。
该研究纳入了 2012 年 1 月至 2018 年 3 月期间进行 G 带核型检测和体外受精/PGT-A 周期的夫妇。根据夫妇的核型将参与者分为两组:A 组:≥1 名患者报告为异染色质变异携带者;B 组:双方均报告为“正常”。我们评估了各组的非整倍体率。我们进行了多变量回归分析,以评估异染色质变异与胚胎非整倍体率之间的关系。
在 946 对夫妇中,48 对(5.0%)报告携带≥1 种异染色质变异。我们共分析了 869 个体外受精/PGT-A 周期(A 组:n=48;B 组:n=82)。各组胚胎倍性率无显著差异。异染色质染色体变异与非整倍体率增加无关(OR=1.04,95%CI:0.85-1.07;p=0.46)。此外,异染色质变异携带者的性别与非整倍体率增加无关(OR 1.02,95%CI 0.81-1.28,p=0.82)。
本研究表明,父母异染色质染色体变异与随后的胚胎非整倍体率之间无关联。当至少一名患者报告核型中存在异染色质变异携带者时,倍性率似乎不会对夫妇产生负面影响。